Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

MedTech portfolio is growing at a CAGR (compounded annual growing rate) of 11%-13%. The company’s non-MedTech operations are ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

The fund owned 40,603 shares of the healthcare product maker’s stock after selling 253 shares during the quarter. Abbott ...

Diversifies Abbott's pharmaceutical products, expanding international growth platform Supports long-term strategy to bolster presence in key global emerging markets Adds substantial R&D spending ...

Gov. Greg Abbott highlighted Texas’ economic growth that continues to surpass that of most countries at a Harris County Republican Party event in Houston.

is questioning Abbott Laboratories' business practices after ... shortage that is leaving Americans scrambling to find the product.

However, sales of these products started declining as the outbreak receded, leading to more uneven revenue growth for the company. Throughout it all, one of Abbott Laboratories' segments has been ...